PRCT
Procept Biorobotics Corp
NASDAQ: PRCT · HEALTHCARE · MEDICAL DEVICES
$24.04
+10.73% today
Updated 2026-04-30
Market cap
$1.24B
P/E ratio
—
P/S ratio
4.01x
EPS (TTM)
$-1.72
Dividend yield
—
52W range
$19 – $67
Volume
1.8M
Procept Biorobotics Corp (PRCT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-43.82M | $-48.34M | $-57.33M | $-80.38M | $-108.00M | $-99.21M | $-48.98M |
| Capital expenditures | $7.61M | $233000.00 | $592000.00 | $2.65M | $25.21M | $4.41M | $9.36M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $1.99M | $2.17M | $3.80M | $10.34M | $19.13M | $31.84M | $47.60M |
| Free cash flow | $-51.43M | $-48.58M | $-57.93M | $-83.03M | $-133.21M | $-103.62M | $-58.34M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $204.19M | — | — | — | — |